Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

ABSTRACT: To determine the effect of ABT-869 plus mFOLFOX6 compared to bevacizumab plus mFOLFOX6 on disease progression in advanced colorectal cancer.

DISEASE(S): Adenocarcinoma,Metastatic Colorectal Cancer,Colorectal Cancer Stage Iv,Adenocarcinoma Of The Rectum,Colorectal Cancer Recurrent,Colorectal Neoplasms,Colorectal Cancer Metastatic,Adenocarcinoma Of The Colon,Advanced Colorectal Cancer

PROVIDER: 2057654 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR